Search results for "polycyclic compounds"

showing 10 items of 373 documents

Permissive and suppressive effects of dexamethasone on enzyme induction in hepatocyte co-cultures.

2002

1. Steroids are known to act as permissive factors in hepatocytes. This study shows that dexamethasone (DEX) is a permissive factor for induction of CYP2B1/2, CYP3A1, CYP2A1 and probably also CYP2C11 in cultures with primary rat hepatocytes. 2. The induction factor of phenobarbital (PB)-induced formation of 16beta-hydroxytestosterone (OHT), a testosterone biotransformation product predominantly formed by CYP2B1, is increased 18-fold by the addition of 32 nM DEX to the culture medium. Interestingly, higher concentrations of DEX up to 1000 nM led to a concentration-dependent maximally 5-fold decrease (p = 0.002) of phenobarbital-induced 16beta-OHT formation compared with the effect observed w…

Malemedicine.medical_specialtyTime FactorsHealth Toxicology and MutagenesisAnti-Inflammatory AgentsBiologyToxicologyBiochemistryDexamethasoneRats Sprague-DawleyEnzyme activatorInternal medicinepolycyclic compoundsmedicineCytochrome P-450 CYP1A1AnimalsCytochrome P-450 CYP3AProtein IsoformsPermissiveEnzyme inducerCytochrome P450 Family 2DexamethasoneCells CulturedPharmacologyCryopreservationDose-Response Relationship DrugBiological activityGeneral MedicineIn vitroCoculture TechniquesRatsEnzyme ActivationEndocrinologymedicine.anatomical_structureLiverSteroid 16-alpha-HydroxylaseHepatocytePhenobarbitalCytochrome P-450 CYP2B1Steroid Hydroxylasesbiology.proteinHepatocytesHydroxytestosteronesAryl Hydrocarbon HydroxylasesExcitatory Amino Acid Antagonistshormones hormone substitutes and hormone antagonistsGlucocorticoidmedicine.drugXenobiotica; the fate of foreign compounds in biological systems
researchProduct

Stacking as a key property for creating nanoparticles with tunable shape: The case of squalenoyl-doxorubicin

2019

The development of elongated nanoparticles for drug delivery is of growing interest in recent years, due to longer blood circulation and improved efficacy compared to spherical counterparts. Squalenoyl-doxorubicin (SQ-Dox) conjugate was previously shown to form elongated nanoparticles with improved therapeutic efficacy and decreased toxicity compared to free doxorubicin. By using experimental and computational techniques, we demonstrate here that the specific physical properties of SQ-Dox, which include stacking and electrostatic interactions of doxorubicin as well as hydrophobic interactions of squalene, are involved in the formation of nanoassemblies with diverse elongated structures. We …

Materials scienceStackingGeneral Physics and AstronomyNanoparticleAntineoplastic AgentsNanotechnology02 engineering and technologysqualene010402 general chemistry01 natural sciencesbioconjugate; cylindrical nanoparticles; doxorubicin; elongated nanoparticles; nanomedicine; squalene; stackingdoxorubicinHydrophobic effectDrug Delivery Systemselongated nanoparticlespolycyclic compoundsGeneral Materials Sciencebioconjugatecylindrical nanoparticlesBioconjugationGeneral Engineering021001 nanoscience & nanotechnologynanomedicine3. Good health0104 chemical sciencesIonic strengthstackingDrug deliveryNanoparticlesNanomedicine0210 nano-technologyHydrophobic and Hydrophilic InteractionsConjugateACS Nano
researchProduct

Chlorine as a Discriminant Element to Establish the Provenance of Central Mediterranean Obsidians

2020

Abstract Chlorine is a minor element present in obsidians in quantities greater than in average igneous rocks. The chlorine concentration in obsidians is generally low, of the order of tenths of wt %, but it exhibits an appreciable differentiation among geological sources. Despite these characteristics, chlorine has rarely been taken into consideration as a possible indicator of obsidian provenance and it does not appear in the chemical analytical tables accompanying the geochemical characterisation of obsidian samples. In this work, after an overview of chlorine geochemistry and cycle, we present thirty-one new electron microprobe (EPMA) analyses, including Cl, of geologic obsidians sample…

Mediterranean climate010506 paleontologyArcheologyProvenanceepma analysesGeochemistrychemistry.chemical_elementConservationobsidian-sources discrimination010502 geochemistry & geophysics01 natural sciencesEducationArchaeologyDiscriminantchemistrychlorine geochemistrypolycyclic compoundsChlorinecentral mediterranean obsidianCC1-960Geology0105 earth and related environmental sciencesOpen Archaeology
researchProduct

Toxic cyanobacterial blooms in reservoirs under a semiarid Mediterranean climate: the magnification of a problem

2007

Sicilian reservoirs constitute the most important water resources available on the island. During summer 2001, the intense water utilization of Lake Arancio reservoir reduced the water level significantly. This coincided with the formation of intense blooms formed by the microcystin-producing cyanobacterium Microcystis aeruginosa. During summer 2003, Lake Arancio was continuously filled and the vertical stratification of the water column was maintained, resulting in 5-6 fold lower cell numbers of Microcystis aeruginosa. For both years a significant linear relationship between microcystin net production and Microcysytis cell division was observed, implying that Microcystis cell numbers can b…

Mediterranean climatemicrocystinMicrocystisMicrocystinsHealth Toxicology and MutagenesisClimateBacterial ToxinsFresh WaterMicrocystinManagement Monitoring Policy and LawToxicologyCyanobacteriaArticleenvironmental managementWater columnMicrocystispolycyclic compoundsMicrocystis aeruginosaMicrocystis aeruginosaSicilychemistry.chemical_classificationbiologyEcologyMediterranean Regionrisk assessmentPlanktothrix rubescenGeneral Medicinebiology.organism_classificationWater levelWater resourceschemistryEnvironmental scienceSeasonsBloomEnvironmental Monitoring
researchProduct

Facile formation of a meso–meso linked porphyrin dimer catalyzed by a manganese(iv)–oxo porphyrin

2011

A manganese(IV)-oxo porphyrin catalyzes C-C bond formation between zinc porphyrins at the meso-position with a two-electron oxidant to afford the meso-meso linked porphyrin dimer efficiently. The meso-meso linked dimer is formed via formation of the porphyrin radical cation, and the rate-determining step in the catalytic cycle is the formation of a manganese(IV)-oxo porphyrin with a two-electron oxidant.

MetalloporphyrinsDimerchemistry.chemical_elementManganeseZincPhotochemistryCatalysisCatalysischemistry.chemical_compoundPolymer chemistrypolycyclic compoundsMaterials Chemistryheterocyclic compoundsChemistryfungiMetals and AlloysGeneral ChemistryBond formationPorphyrinSurfaces Coatings and FilmsElectronic Optical and Magnetic Materialscarbohydrates (lipids)Manganese CompoundsRadical ionCatalytic cycleCeramics and CompositesDimerizationChemical Communications
researchProduct

In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.

2010

ABSTRACT Anidulafungin, micafungin, and caspofungin in vitro activities against Candida metapsilosis , C. orthopsilosis , and C. parapsilosis were evaluated by MICs and time-kill methods. All echinocandins showed lower MICs (mean MICs, 0.05 to 0.71 mg/liter) and the highest killing rates (−0.06 to −0.05 CFU/ml/h) for C. metapsilosis and C. orthopsilosis rather than for C. parapsilosis (mean MICs, 0.59 to 1.68 mg/liter). Micafungin and anidulafungin killing rates were greater than those determined for caspofungin. None of the echinocandins had fungicidal activity against C. parapsilosis .

Microbiological TechniquesAntifungal AgentsTime FactorsMicrobial Sensitivity TestsIn Vitro TechniquesAnidulafunginMicrobiologychemistry.chemical_compoundEchinocandinsLipopeptidesCandida metapsilosisCaspofunginmedicinepolycyclic compoundsPharmacology (medical)CandidaPharmacologybiologyMicafunginFungi imperfectibiology.organism_classificationbacterial infections and mycosesIn vitroFungicideInfectious DiseaseschemistrySusceptibilityMicafunginAnidulafunginCaspofunginEchinocandinsmedicine.drugAntimicrobial agents and chemotherapy
researchProduct

Characterization of Acinetobacter baumannii from intensive care units and home care patients in Palermo, Italy.

2011

AbstractIn this study 45 isolates of Acinetobacter baumannii identified from patients in intensive care units of three different hospitals and from pressure ulcers in home care patients in Palermo, Italy, during a 3-month period in 2010, were characterized. All isolates were resistant to at least three classes of antibiotics, but susceptible to colistin and tygecycline. Forty isolates were non-susceptible to carbapenems. Eighteen and two isolates, respectively, carried the blaOXA-23-like and the blaOXA-58-like genes. One strain carried the VIM-4 gene. Six major rep-PCR subtype clusters were defined, including isolates from different hospitals or home care patients. The sequence type/pulsed …

Microbiology (medical)Acinetobacter baumanniimedicine.medical_specialtyPediatricsSettore MED/07 - Microbiologia E Microbiologia ClinicaGenotypeDrug resistanceMicrobial Sensitivity Testshome care patientsintensive care unitbeta-Lactamaseslaw.inventionlawmultidrug resistanceIntensive careInternal medicineDrug Resistance Multiple BacterialGenotypepolycyclic compoundsmedicinePulsed-field gel electrophoresisCluster AnalysisHumansCross Infectionbiologybusiness.industryGeneral Medicinebiochemical phenomena metabolism and nutritionbacterial infections and mycosesbiology.organism_classificationIntensive care unitHome Care ServicesAcinetobacter baumanniiAnti-Bacterial AgentsElectrophoresis Gel Pulsed-FieldCommunity-Acquired InfectionsMolecular TypingIntensive Care UnitsInfectious DiseasesItalyColistinMultilocus sequence typingepidemiologybusinesshome caremedicine.drugAcinetobacter InfectionsMultilocus Sequence Typing
researchProduct

Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae Carbapenemase 3 in an intensive care unit in Italy

2010

Gram-negative pathogens producing carbapenemases represent an alarming clinical threat with serious effects on patient outcomes ([3][1], [7][2]). In 2001, Yigit et al. ([11][3]) reported a novel β-lactamase termed “ K lebsiella pneumoniae carbapenemase” (KPC-1) in North Carolina. KPC-producing

Microbiology (medical)AdultMaleSettore MED/07 - Microbiologia E Microbiologia ClinicaAdolescentGenotypeKlebsiella pneumoniaemedicine.medical_treatmentTreatment outcomeMicrobial Sensitivity TestsKlebsiella pneumoniae carbapenem UTI outbreakbeta-Lactamaseslaw.inventionDisease courseMicrobiologyDisease OutbreaksBacterial proteinBacterial Proteinslawpolycyclic compoundsMedicineHumansLetters to the EditorAgedAged 80 and overbiologybusiness.industryOutbreakKlebsiella infectionsSequence Analysis DNAMiddle Agedbacterial infections and mycosesbiology.organism_classificationIntensive care unitDNA FingerprintingAnti-Bacterial AgentsBacterial Typing TechniquesKlebsiella InfectionsIntensive Care UnitsKlebsiella pneumoniaeTreatment OutcomeItalyBeta-lactamaseFemalebusiness
researchProduct

New β-Lactam-β-Lactamase Inhibitor Combinations.

2020

The limited armamentarium against drug-resistant Gram-negative bacilli has led to the development of several novel β-lactam-β-lactamase inhibitor combinations (BLBLIs). In this review, we summarize their spectrum of in vitro activities, mechanisms of resistance, and pharmacokinetic-pharmacodynamic (PK-PD) characteristics. A summary of available clinical data is provided per drug. Four approved BLBLIs are discussed in detail. All are options for treating multidrug-resistant (MDR) Enterobacterales and Pseudomonas aeruginosa Ceftazidime-avibactam is a potential drug for treating Enterobacterales producing extended-spectrum β-lactamase (ESBL), Klebsiella pneumoniae carbapenemase (KPC), AmpC, an…

Microbiology (medical)DrugImipenemBacilliEpidemiologyKlebsiella pneumoniaemedia_common.quotation_subjectMicrobial Sensitivity Testsmedicine.disease_causebeta-LactamsMeropenemMicrobiologyDrug Resistance Multiple BacterialGram-Negative Bacteriapolycyclic compoundsmedicinemedia_commonGeneral Immunology and MicrobiologybiologyPseudomonas aeruginosabusiness.industryPublic Health Environmental and Occupational Healthbiochemical phenomena metabolism and nutritionbacterial infections and mycosesbiology.organism_classificationCeftazidime/avibactamAcinetobacter baumanniiDrug CombinationsInfectious DiseasesbacteriaErratumbusinessbeta-Lactamase Inhibitorsmedicine.drugClinical microbiology reviews
researchProduct

In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii

2005

To compare the activity of linezolid with a range of drugs used in the treatment of Mycobacterium kansasii infections.The percentages of resistant isolates against isoniazid, rifampicin and ethambutol were 2.9%, 1.9% and 2.9%, respectively. All isolates were susceptible to clarithromycin and moxifloxacin both with MIC(90) values of 0.125 mg/L. Linezolid was active against all isolates with MIC(50) and MIC(90) values of 0.5 and 1 mg/L, respectively, both below the susceptibility breakpoint established for mycobacteria.Linezolid, clarithromycin or moxifloxacin, could be used as alternative drugs for treatment of infections due to rifampicin-resistant isolates as well as short-course or interm…

Microbiology (medical)MoxifloxacinMicrobial Sensitivity TestsBiologyMicrobiologychemistry.chemical_compoundMoxifloxacinClarithromycinClarithromycinAcetamidesDrug Resistance Bacterialpolycyclic compoundsmedicineHumansheterocyclic compoundsPharmacology (medical)OxazolidinonesEthambutolAntibacterial agentPharmacologyMycobacterium kansasiiAza CompoundsIsoniazidLinezolidbiochemical phenomena metabolism and nutritionbacterial infections and mycosesbiology.organism_classificationAnti-Bacterial AgentsInfectious DiseaseschemistryMycobacterium kansasiiLinezolidQuinolinesbacteriaRifampicinFluoroquinolonesmedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct